{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:12:20Z","timestamp":1785726740413,"version":"3.56.0"},"reference-count":15,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>This Special Issue aims to provide an updated overview of the current state and future perspectives of botulinum toxin treatment for migraine [...]<\/jats:p>","DOI":"10.3390\/toxins16120530","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T04:15:03Z","timestamp":1733804103000},"page":"530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Botulinum Toxin and Migraine: Goals and Perspectives"],"prefix":"10.3390","volume":"16","author":[{"given":"Maria Pia","family":"Prudenzano","sequence":"first","affiliation":[{"name":"Headache Center, Neurological Clinic, \u201cL. Amaducci\u201d, AOUC Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A Phase-by-Phase Review of Migraine Pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/head.13529","article-title":"CGRP and the Trigeminal System in Migraine","volume":"59","author":"Iyengar","year":"2019","journal-title":"Headache"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Becker, W.J. (2020). Botulinum Toxin in the Treatment of Headache. Toxins, 12.","DOI":"10.3390\/toxins12120803"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0333102416636843","article-title":"Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors\u2019 responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?","volume":"36","author":"Zhang","year":"2016","journal-title":"Cephalalgia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s13311-022-01230-x","article-title":"The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine","volume":"19","author":"Cohen","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1007\/s00415-024-12512-z","article-title":"Effectiveness and safety of pharmacological prophylaxis for chronic migraine: A systematic review and network meta-analysis","volume":"271","author":"Zhao","year":"2024","journal-title":"J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/head.14743","article-title":"Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials","volume":"64","author":"Silberstein","year":"2024","journal-title":"Headache"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3331024241274266","DOI":"10.1177\/03331024241274266","article-title":"Systematic review and meta-analysis of Neck Disability Index and Numeric Pain Rating Scale in patients with migraine and tension-type headache","volume":"44","author":"Younis","year":"2024","journal-title":"Cephalalgia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/head.14750","article-title":"Early effect of onabotulinumtoxinA on EEG-based functional connectivity in patients with chronic migraine: A pilot study","volume":"64","author":"Conti","year":"2024","journal-title":"Headache"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/03331024211067775","article-title":"FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine","volume":"42","author":"Stovner","year":"2022","journal-title":"Cephalalgia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/head.13843","article-title":"Dual Therapy with Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?","volume":"60","author":"Pellesi","year":"2020","journal-title":"Headache"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40122-021-00264-x","article-title":"Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review","volume":"10","author":"Blumenfeld","year":"2021","journal-title":"Pain Ther."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Scuteri, D., Tonin, P., Nicotera, P., Vulnera, M., Altieri, G.C., Tarsitano, A., Bagetta, G., and Corasaniti, M.T. (2022). Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine. Toxins, 14.","DOI":"10.3390\/toxins14080529"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1007\/s10072-022-06195-5","article-title":"The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: A reliable option for the optimal treatment of chronic migraine","volume":"43","author":"Guerzoni","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-024-01086-z","article-title":"Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review","volume":"38","author":"Salim","year":"2024","journal-title":"CNS Drugs"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/12\/530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:50:56Z","timestamp":1760115056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/12\/530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["toxins16120530"],"URL":"https:\/\/doi.org\/10.3390\/toxins16120530","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}